Evidence-Based Neurocritical Care

The Neurohospitalist

Volumn 4, Issue 2, 2014, Pages 102-108

  Goodman, Diana J ^a   Kumar, Monisha A ^b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cerebrovascular trauma; intracranial hemorrhage; neurocritical care; status epilepticus; subarachnoid hemorrhage

Indexed keywords

EID: 84992884514     PISSN: 19418744     EISSN: 19418752     Source Type: Journal    
DOI: 10.1177/1941874413507928     Document Type: Article

References (43)

1. Hacke W Schwab S Horn M Spranger M De Georgia M von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch. Neurol. 1996; 53(4):309–315.
2. Juttler E Schwab S Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007; 38(9):2518–2525.
3. Vahedi K Vicaut E Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial). Stroke. 2007; 38(9):2506–2517.
4. Hofmeijer J Kappelle LJ Algra A Amelink GJ van Gijn J van der Worp HB. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009; 8(4):326–333.
5. Vahedi K Hofmeijer J Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007; 6(3):215–222.
6. Mayer SA Brun NC Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008; 358(20):2127–2137.
7. Mayer SA Brun NC Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005; 352(8):777–785.
8. Morgenstern LB Hemphill JC III Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2010; 41(9):2108–2129.
9. Anderson CS Heeley E Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013; 368(25):2355–2365.
10. Anderson CS Huang Y Arima H, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT). Stroke. 2010; 41(2):307–312.
11. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010; 38(2):637–648.
12. Morgan T Zuccarello M Narayan R Keyl P Lane K Hanley D. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. Acta Neurochir Suppl. 2008; 105: 147–151.
13. Daverat P Castel JP Dartigues JF Orgogozo JM. Death and functional outcome after spontaneous intracerebral hemorrhage. a prospective study of 166 cases using multivariate analysis. Stroke. 1991; 22(1):1–6.
14. Tuhrim S Dambrosia JM Price TR, et al. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1991; 29(6):658–663.
15. Morgan T Awad I Keyl P Lane K Hanley D. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008; 105: 217–220.
16. Da Pian R Bazzan A Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res. 1984; 6(3):145–151.
17. Kirollos RW Tyagi AK Ross SA van Hille PT Marks PV. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery. 2001; 49(6):1378–1386; discussion 1386-1377.
18. Mendelow AD Gregson BA Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005; 365(9457):387–397.
19. Mendelow AD Gregson BA Rowan EN Murray GD Gholkar A Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013; 382(9890):397–408.
20. Molyneux A Kerr R Stratton I, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. J Stroke Cerebrovasc Dis. 2002; 11(6):304–314.
21. Molyneux AJ Kerr RS Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005; 366(9488):809–817.
22. Molyneux AJ Kerr RS Birks J, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the international subarachnoid aneurysm trial (ISAT): long-term follow-up. Lancet Neurol. 2009; 8(5):427–433.
23. Hillman J Fridriksson S Nilsson O Yu Z Saveland H Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002; 97(4):771–778.
24. Macdonald RL Higashida RT Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011; 10(7):618–625.
25. Westermaier T Stetter C Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med. 2010; 38(5):1284–1290.
26. Wong GK Poon WS Chan MT, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010; 41(5):921–926.
27. Allen GS Ahn HS Preziosi TJ, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983; 308(11):619–624.
28. Zwienenberg-Lee M Hartman J Rudisill N, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke. 2008; 39(6):1759–1765.
29. Acosta JA Yang JC Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998; 186(5):528–533.
30. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007; 24(suppl 1):S1–S106.
31. Chesnut RM Temkin N Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012; 367(26):2471–2481.
32. Cooper DJ Rosenfeld JV Murray L, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011; 364(16):1493–1502.
33. Clifton GL Valadka A Zygun D, et al. Very early hypothermia induction in patients with severe brain injury (the national acute brain injury study: hypothermia II): a randomised trial. Lancet Neurol. 2011; 10(2):131–139.
34. Wright DW Kellermann AL Hertzberg VS, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007; 49(4):391–402, 402.e391–e392.
35. Xiao G Wei J Yan W Wang W Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care. 2008; 12(2):R61.
36. Roberts I Yates D Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004; 364(9442):1321–1328.
37. Edwards P Arango M Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005; 365(9475):1957–1959.
38. Finfer S Bellomo R Boyce N French J Myburgh J Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350(22):2247–2256.
39. Myburgh J Cooper DJ Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007; 357(9):874–884.
40. Agarwal P Kumar N Chandra R Gupta G Antony AR Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007; 16(6):527–532.
41. Misra UK Kalita J Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. 2006; 67(2):340–342.
42. Rossetti AO Milligan TA Vulliemoz S Michaelides C Bertschi M Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care. 2011; 14(1):4–10.
43. Brophy GM Bell R Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012; 17(1):3–23.